In Thursday’s Wall Street session, Co-Diagnostics Inc (NASDAQ:CODX) shares traded at $0.28, down -3.15% from the previous session.
CODX stock price is now -8.08% away from the 50-day moving average and -60.25% away from the 200-day moving average. The market capitalization of the company currently stands at $9.34M.
With the price target maintained at $5, Sidoti recently Downgraded its rating from Buy to Neutral for Co-Diagnostics Inc (NASDAQ: CODX). On December 29, 2021, Sidoti recently initiated its ‘Buy’ rating on the stock quoting a target price of $14, while ‘Maxim Group’ rates the stock as ‘Hold’
A total of 9.00% of the company’s stock is owned by insiders.
During the past 12 months, Co-Diagnostics Inc has had a low of $0.23 and a high of $2.23. As of last week, the company has a debt-to-equity ratio of 0.04, a current ratio of 4.43, and a quick ratio of 4.23. The fifty day moving average price for CODX is $0.30142 and a two-hundred day moving average price translates $0.69696 for the stock.
The latest earnings results from Co-Diagnostics Inc (NASDAQ: CODX) was released for 2025-03-31. The net profit margin was -6318.09% and return on equity was -56.80% for CODX. The company reported revenue of $50000.0 for the quarter, compared to $0.47 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -89.32 percent.
